Suppr超能文献

疟疾相关继发性噬血细胞性淋巴组织细胞增生症:一例报告

Malaria-associated secondary hemophagocytic lymphohistiocytosis: A case report.

作者信息

Zhou Xiao, Duan Mei-Li

机构信息

Department of Critical Care Medicine, Beijing Friendship Hospital, Capital Medical University, Beijing 100054, China.

出版信息

World J Clin Cases. 2021 Aug 6;9(22):6403-6409. doi: 10.12998/wjcc.v9.i22.6403.

Abstract

BACKGROUND

Malaria-associated secondary hemophagocytic lymphohistiocytosis (HLH) is rare. Moreover, the literature on malaria-associated HLH is sparse, and there are no similar cases reported in China.

CASE SUMMARY

We report the case of a 29-year-old woman with unexplained intermittent fever who was admitted to our hospital due to an unclear diagnosis. The patient concealed her history of travel to Nigeria before onset. We made a diagnosis of malaria-associated secondary HLH. The treatment strategy for this patient included treatment of the inciting factor (artemether for 9 d followed by artemisinin for 5 d), the use of immunosuppressants (steroids, intravenous immunoglobulin) and supportive care. The patient was discharged in normal physical condition after 25 d of intensive care. No relapses were documented on follow-up at six months and 1 year.

CONCLUSION

Early diagnosis of the primary disease along with timely intervention and a multidisciplinary approach can help patients achieve a satisfactory outcome.

摘要

背景

疟疾相关的继发性噬血细胞性淋巴组织细胞增生症(HLH)较为罕见。此外,关于疟疾相关HLH的文献稀少,且中国尚无类似病例报道。

病例摘要

我们报告了一名29岁不明原因间歇性发热女性的病例,该患者因诊断不明入院。患者发病前隐瞒了前往尼日利亚的旅行史。我们诊断为疟疾相关的继发性HLH。该患者的治疗策略包括治疗诱发因素(蒿甲醚治疗9天,随后青蒿素治疗5天)、使用免疫抑制剂(类固醇、静脉注射免疫球蛋白)及支持治疗。经过25天的重症监护,患者身体状况正常出院。随访6个月和1年时均未记录到复发情况。

结论

对原发疾病的早期诊断以及及时干预和多学科方法有助于患者获得满意的治疗效果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cb0/8362573/c69b603ee824/WJCC-9-6403-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验